Ming Ye, Hu Yun, Li Yuyue, Yu Jinfeng, He Haojue, Zheng Leilei
The Affiliated Stomatology Hospital, Chongqing Medical University, Chongqing, 401147, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, 401147, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, 401147, China.
The Affiliated Stomatology Hospital, Chongqing Medical University, Chongqing, 401147, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, 401147, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, 401147, China.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:138-145. doi: 10.1016/j.ijporl.2017.12.013. Epub 2017 Dec 14.
The purpose of this study was to assess, through a systematic review and meta-analysis, the efficacy of maxillary protraction appliances (MPAs) on improving pharyngeal airway dimensions in growing class III patients with maxillary retrognathism.
An electronic search in PubMed, Cochrane Library, Web of Science, and EMBASE was until September 2nd, 2017. The assessments of methodological quality of the selected articles were performed using the Newcastle-Ottawa Scale. Review Manager 5.3 (provided by the Cochrane Collaboration) was used to synthesize the effects of MPAs on pharyngeal airway dimensions.
Following full-text articles evaluation for eligibility, 6 studies (168 treated subjects and 140 untreated controls) were included in final quantitative synthesis and they were all high-quality. Compared to untreated control groups, the treatment groups had increased significantly nasopharyngeal airway dimensions with the following measurements: PNS-AD1 (fixed: mean difference, 1.33 mm, 95% CI, 0.48mm-2.19 mm, P = .002), PNS-AD2 (random: mean difference, 1.91 mm, 95% CI, 0.02mm-3.81 mm, P = .05), aerial nasopharyngeal area (fixed: mean difference, 121.91 mm, 95% CI, 88.70 mm-155.11 mm, P < .00001) and total nasopharyngeal area (fixed: mean difference, 142.73 mm, 95% CI, 107.90 mm-177.56 mm, P < .00001). Meanwhile, McNamara's upper pharynx dimension (fixed: mean difference, 0.96 mm, 95% CI, 0.29mm-1.63 mm, P = .005), which was highly related to post-palatal airway dimension, was also improved significantly. However, no statistically significant differences in adenoidal nasopharyngeal area (P > .05) and McNamara's lower pharynx dimension (P > .05) existed.
MPAs can increase post-palatal and nasopharyngeal airway dimensions in growing skeletal class III subjects with maxillary retrusion. It may be suggested that MPAs have the potential to reduce the risk of obstructive sleep apnea syndrome in children with maxillary retrusion by enlarging airway space.
本研究旨在通过系统评价和荟萃分析,评估上颌前牵引矫治器(MPAs)对改善上颌后缩的生长发育期III类患者咽气道尺寸的疗效。
截至2017年9月2日,在PubMed、Cochrane图书馆、科学网和EMBASE中进行电子检索。使用纽卡斯尔-渥太华量表对所选文章的方法学质量进行评估。采用Review Manager 5.3(由Cochrane协作网提供)综合分析MPAs对咽气道尺寸的影响。
在对全文进行纳入标准评估后,最终定量分析纳入了6项研究(168例治疗对象和140例未治疗对照),且所有研究质量均较高。与未治疗对照组相比,治疗组的鼻咽气道尺寸有显著增加,具体测量结果如下:PNS-AD1(固定效应模型:平均差值,1.33 mm,95%置信区间,0.48mm - 2.19 mm,P = .002),PNS-AD2(随机效应模型:平均差值,1.91 mm,95%置信区间,0.02mm - 3.81 mm,P = .05),鼻咽气腔面积(固定效应模型:平均差值,121.91 mm,95%置信区间,88.70 mm - 155.11 mm,P < .00001)和总鼻咽面积(固定效应模型:平均差值,142.73 mm,95%置信区间,107.90 mm - 177.56 mm,P < .00001)。同时,与腭后气道尺寸高度相关的McNamara上咽尺寸(固定效应模型:平均差值,0.96 mm,95%置信区间,0.29mm - 1.63 mm,P = .005)也有显著改善。然而,腺样体鼻咽面积(P > .05)和McNamara下咽尺寸(P > .05)无统计学显著差异。
MPAs可增加上颌后缩的生长发育期骨骼III类患者的腭后和鼻咽气道尺寸。提示MPAs可能通过扩大气道空间降低上颌后缩儿童患阻塞性睡眠呼吸暂停综合征的风险。